ConductScience.org, home

Paper40487451

Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYC.

Littler S and 9 others. iScience, 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYC. Papers, record 40487451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40487451

Download JSON
Cell line
OVCAR-3234 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYC.
PubMed
Journal
iScience
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.49, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Littler SSamantha
2Barnes BMBethany M
3Owen RRhys
4Nelson LLouisa
5Tighe AAnthony
6Lin IHI-Hsuan
7Osborne HCHugh C
8Schmidt CKChristine K
9McGrail JCJoanne C
10Taylor SSStephen S

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116912073Validating Aurora B as an anti-cancer drug target.J Cell Sci2006https://conductscience.org/library/papers/16912073PubMed
220162290Re-evaluating the role of Tao1 in the spindle checkpoint.Chromosoma2010https://conductscience.org/library/papers/20162290PubMed
323104886STAR: ultrafast universal RNA-seq aligner.Bioinformatics2013https://conductscience.org/library/papers/23104886PubMed
420643922Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20643922PubMed
52182320Negative autoregulation of c-myc transcription.EMBO J1990https://conductscience.org/library/papers/2182320PubMed
631068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019https://conductscience.org/library/papers/31068700PubMed
732071436Target gene-independent functions of MYC oncoproteins.Nat Rev Mol Cell Biol2020https://conductscience.org/library/papers/32071436PubMed
817157259SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes.Mol Cell2006https://conductscience.org/library/papers/17157259PubMed
929847804Identification of Drivers of Aneuploidy in Breast Tumors.Cell Rep2018https://conductscience.org/library/papers/29847804PubMed
1031694914SUMOylation down-regulates rDNA transcription by repressing expression of upstream-binding factor and proto-oncogene c-Myc.J Biol Chem2019https://conductscience.org/library/papers/31694914PubMed
1118384750Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling.Biochem Biophys Res Commun2008https://conductscience.org/library/papers/18384750PubMed
1234508258The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34508258PubMed
1337474739The SUMO-NIP45 pathway processes toxic DNA catenanes to prevent mitotic failure.Nat Struct Mol Biol2023https://conductscience.org/library/papers/37474739PubMed
1412098700Sustained loss of a neoplastic phenotype by brief inactivation of MYC.Science2002https://conductscience.org/library/papers/12098700PubMed
1538321218MYC targeting by OMO-103 in solid tumors: a phase 1 trial.Nat Med2024https://conductscience.org/library/papers/38321218PubMed
1631974379Chromosome arm aneuploidies shape tumour evolution and drug response.Nat Commun2020https://conductscience.org/library/papers/31974379PubMed
1727273739Cofactor squelching: Artifact or fact?Bioessays2016https://conductscience.org/library/papers/27273739PubMed
1835562350MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.Nat Commun2022https://conductscience.org/library/papers/35562350PubMed
1918716624Modelling Myc inhibition as a cancer therapy.Nature2008https://conductscience.org/library/papers/18716624PubMed
2020519624Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.Blood2010https://conductscience.org/library/papers/20519624PubMed

See all 92 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42819173Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications.Front Oncol2026https://conductscience.org/library/papers/42819173PubMed
42019804A Landscape Analysis of Human SUMOylation.Mol Cell Proteomics2026https://conductscience.org/library/papers/42019804PubMed
41857765Transcriptome-driven constraint-based modelling reveals metabolic targets for ovarian cancer.Cancer Metab2026https://conductscience.org/library/papers/41857765PubMed
40909841Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer.medRxiv2025https://conductscience.org/library/papers/40909841PubMed
40466638Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer.Cell Rep Med2025https://conductscience.org/library/papers/40466638PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene
PML5371PubTator's text mininghttps://conductscience.org/library/genes/5371NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40487451

GET https://conductscience.org/api/papers/v1/40487451/references?page=2